Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolic syndrome: relevance to antidepressant treatment.

Literature DB >> 17136222

Metabolic syndrome: relevance to antidepressant treatment.

Pratap Chokka¹, Manuel Tancer, Vikram K Yeragani.

Abstract

Entities: Disease

Mesh：

Substances：
Antidepressive Agents

Year: 2006 PMID： 17136222 PMCID： PMC1635794

Source DB: PubMed Journal: J Psychiatry Neurosci ISSN： 1180-4882 Impact factor: 6.186

Keyword Cloud
Cited

× No keyword cloud information.

6 in total

1. Paternal dapoxetine administration induced deterioration in reproductive performance, fetal outcome, sexual behavior and biochemistry of male rats.

Authors: R ElMazoudy; N AbdelHameed; A ElMasry
Journal: Int J Impot Res Date: 2015-09-24 Impact factor: 2.896

2. The lack of association between components of metabolic syndrome and treatment resistance in depression.

Authors: Marina Sagud; Alma Mihaljevic-Peles; Suzana Uzun; Bjanka Vuksan Cusa; Oliver Kozumplik; Suzan Kudlek-Mikulic; Maja Mustapic; Ivan Barisic; Dorotea Muck-Seler; Nela Pivac
Journal: Psychopharmacology (Berl) Date: 2013-04-12 Impact factor: 4.530

3. Impact of Muscarinic M₃ Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study.

Authors: Yen-Hao Tran; Catharina C M Schuiling-Veninga; Jorieke E H Bergman; Henk Groen; Bob Wilffert
Journal: CNS Drugs Date: 2017-06 Impact factor: 5.749

Metabolic syndrome: relevance to antidepressant treatment.

1. Paternal dapoxetine administration induced deterioration in reproductive performance, fetal outcome, sexual behavior and biochemistry of male rats.

2. The lack of association between components of metabolic syndrome and treatment resistance in depression.

3. Impact of Muscarinic M₃ Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study.

Review 4. Increased Risk of Metabolic Syndrome in Antidepressants Users: A Mini Review.

5. Longitudinal DNA methylation dynamics as a practical indicator in clinical epigenetics.

6. Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus.

Metabolic syndrome: relevance to antidepressant treatment.

1. Paternal dapoxetine administration induced deterioration in reproductive performance, fetal outcome, sexual behavior and biochemistry of male rats.

2. The lack of association between components of metabolic syndrome and treatment resistance in depression.

3. Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study.

Review 4. Increased Risk of Metabolic Syndrome in Antidepressants Users: A Mini Review.

5. Longitudinal DNA methylation dynamics as a practical indicator in clinical epigenetics.

6. Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus.

3. Impact of Muscarinic M₃ Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study.